The Cancer Research Institute (CRI) has appointed Alicia Zhou, PhD, as its new Chief Executive Officer (CEO).
9-Sep-2024 12:10 PM EDT
Add to Favorites
CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.
6-Sep-2024 12:20 PM EDT
Add to Favorites
CRI awarded over $22 million to leading cancer immunotherapy researchers in the 2024 fiscal year, amounting to 64 awards at 42 institutions.
8-Aug-2024 10:00 AM EDT
Add to Favorites
CRI has announced its new class of 2024 Scientists Taking Risks (STARs) grant recipients who are expert cancer immunotherapy researchers.
5-Aug-2024 11:00 AM EDT
Add to Favorites
CRI helped commission a poll of oncologists who say that much more research is required to holistically tackle non-small cell lung cancer.
24-Jan-2024 8:50 AM EST
Add to Favorites
The Cancer Research Institute and Lance Kawaguchi with the #SouthPoleTrek4Cancer ring in the Nasdaq Stock Market Closing Bell.
19-Dec-2023 10:15 AM EST
Add to Favorites
CRI's 2023 Patient Immunotherapy Summit is now available on-demand for the benefit of cancer patients, families, caregivers, and scientists.
6-Dec-2023 1:30 PM EST
Add to Favorites
The Cancer Research Institute is proudly awarding Dr. Ananda Goldrath with the 2023 Fredrick W. Alt award for New Discoveries in Immunology.
27-Oct-2023 2:45 PM EDT
Add to Favorites
The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT
Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT
The mission of the Cancer Research Institute is to save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
